• Loading stock data...
Est. 2004

Wednesday 03/6/2019
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Patent

  • 12:33 PM

    WEST PALM BEACH, FL / ACCESSWIRE / November 21, 2017 / Alliance BioEnergy Plus, Inc. (“ALLM“) (OTCQB: ALLM) (the “Company”) today announced that it has filed its fifteenth patent application, this time focusing on the design of its commercial scale CTS reactors. With four issued patents and now fifteen filed and pending patents, the protection surrounding the CTS process is becoming more and more formidable. As the Company prepares to launch its CTS process commercially, the protection of its intellectual property

    Read more
  • 1:38 PM

    NEW YORK, Oct. 05, 2017, AXIM, (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 14/982,610, a patent that claims the use of an ophthalmic solution comprising cannabinoids for the treatment of glaucoma and symptomatic relief of conjunctival inflammation. A Notice of Allowance is issued after the USPTO makes a determination that a

    Read more
  • 9:41 AM

    Customizable function allows for unique branding and marketing capabilities PR Newswire SANTA ANA, Calif., June 13, 2017, KSHB, SANTA ANA, Calif., June 13, 2017 /PRNewswire/ — Kush Bottles, Inc. (OTCQB: KSHB), a provider of packaging, supplies, accessories and branding solutions for the regulated cannabis industry, announced today the U.S. Patent Office has approved a patent for a unique customizable mechanism on one of its best-selling child resistant packaging products. The patent for invention number US20160167844 covers the configuration of the Company’s

    Read more
  • 7:14 AM

    NORTHVALE, N.J., May 31, 2017, ELTP, (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled “Abuse-Resistant Oral Dosage Forms and Method of Use Thereof” issued March 22, 2017. This patent expands the intellectual property for the Company’s opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.

    Read more
  • Nemus Logo
    8:38 AM

    COSTA MESA, CA–NMUS, (Marketwired – May 9, 2017) – NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that an additional United States patent has been granted covering the company’s proprietary prodrug of THC, THC-valine-hemisuccinate (THCVHS), as well as other amide-ester forms of cannabinoid-based molecules, for use in the treatment of glaucoma. This second patent, which is also licensed to Nemus by the University of Mississippi, further expands the intellectual property (IP) estate into methods of delivery of THCVHS into the eye, by formulating

    Read more
  • 9:57 AM

    Patent Describes Use of Self-Assembling Peptidomimetics to Create Barriers that Prevent Movement of Bodily Fluids and Contaminants, as well as Other Applications FRAMINGHAM, MA–(Marketwired – Feb 2, 2017) – Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, announced that the U.S. Patent and Trademark Office has issued a broad method-of-use patent for products that contain self-assembling peptidomimetics (U.S. Patent number 9,511,113). The patent is assigned to the

    Read more
Public Wire Banner